Lifeboat Foundation

MIT researchers and colleagues have demonstrated a way to precisely control the size, composition, and other properties of nanoparticles key to the reactions involved in a variety of clean energy and environmental technologies. They did so by leveraging ion irradiation, a technique in which beams of charged particles bombard a material.

They went on to show that nanoparticles created this way have superior performance over their conventionally made counterparts.

“The materials we have worked on could advance several technologies, from fuel cells to generate CO₂-free electricity to the production of clean hydrogen feedstocks for the chemical industry [through electrolysis cells],” says Bilge Yildiz, leader of the work and a professor in MIT’s Department of Nuclear Science and Engineering and Department of Materials Science and Engineering.

With 3D inkjet printing systems, engineers can fabricate hybrid structures that have soft and rigid components, like robotic grippers that are strong enough to grasp heavy objects but soft enough to interact safely with humans.

These multimaterial 3D printing systems utilize thousands of nozzles to deposit tiny droplets of resin, which are smoothed with a scraper or roller and cured with UV light. But the smoothing process could squish or smear resins that cure slowly, limiting the types of materials that can be used.

Researchers from MIT, the MIT spinout Inkbit, and ETH Zurich have developed a new 3D inkjet printing system that works with a much wider range of materials. Their printer utilizes computer vision to automatically scan the 3D printing surface and adjust the amount of resin each nozzle deposits in real time to ensure no areas have too much or too little material.

OpenAI has a third CEO in just a few days after the turmoil following Sam Altman’s firing.

OpenAI has a third CEO in three days: Emmett Shear.

Emmett Shear has a big job on his hands to fix OpenAI’s turmoil.

Continue reading “OpenAI’s new CEO is Twitch co-founder Emmett Shear” »

Greg Brockman, OpenAI co-founder, is also joining Microsoft to lead a new advanced AI research team.

Microsoft is hiring former OpenAI CEO Sam Altman and co-founder Greg Brockman.

Altman was fired from OpenAI on Friday, after the board said it “no longer has confidence in his ability to continue leading OpenAI.” After a weekend of negotiations to potentially bring Altman back to OpenAI, Microsoft CEO Satya Nadella announced that both Sam Altman and Greg Brockman will be joining to lead Microsoft’s new advanced AI research team.

Continue reading “Microsoft hires former OpenAI CEO Sam Altman” »

A University of Texas at Dallas bioengineer has developed synthetic enzymes that can control the behavior of the signaling protein Vg1, which plays a key role in the development of muscle, bone and blood in vertebrate embryos.

The team of researchers is using a new approach, called the Synthetic Processing (SynPro) system, in zebrafish to study how Vg1 is formed. By learning the molecular rules of signal formation in a developing animal, researchers aim to engineer mechanisms – such as giving cells new instructions – that could play a role in treating or preventing disease.

Dr. P.C. Dave P. Dingal, assistant professor of bioengineering in the Erik Jonsson School of Engineering and Computer Science, and his colleagues published their research online Oct. 16 in Proceedings of the National Academy of Sciences.

Autoimmune disorders are among the most prevalent chronic diseases across the globe. Emerging treatments for autoimmune disorders focus on “adoptive cell therapies,” or those using cells from a patient’s own body to achieve immunosuppression. These therapeutic cells are recognized by the patient’s body as “self,” therefore limiting side effects, and are specifically engineered to localize the intended therapeutic effect.

In treating autoimmune diseases, current adoptive cell therapies have largely centered around the regulatory T cell (T_reg), which is defined by the expression of the Forkhead box protein 3, orFoxp3. Although T_regs offer great potential, using them for therapeutic purposes remains a major challenge. In particular, current delivery methods result in inefficient engineering of T cells.

T_regs only compose approximately 5%–10% of circulating peripheral blood mononuclear cells. Furthermore, T_regs lack more specific surface markers that differentiate them from other T cell populations. These hurdles make it difficult to harvest, purify and grow T_regs to therapeutically relevant numbers. Although there are additional tissue-resident T_regs in non-lymphoid organs such as in skeletal muscle and visceral adipose tissue, these T_regs are severely inaccessible and low in number.

Once inflation comes to an end, and all the energy that was inherent to space itself gets converted into particles, antiparticles, photons, etc., all the Universe can do is expand and cool. Everything smashes into one another, sometimes creating new particle/antiparticle pairs, sometimes annihilating pairs back into photons or other particles, but always dropping in energy as the Universe expands.

The Universe never reaches infinitely high temperatures or densities, but still attains energies that are perhaps a trillion times greater than anything the LHC can ever produce. The tiny seed overdensities and underdensities will eventually grow into the cosmic web of stars and galaxies that exist today. 13.8 billion years ago, the Universe as-we-know-it had its beginning. The rest is our cosmic history.

Every cell in the human body contains the same genetic instructions, encoded in its DNA. However, out of about 30,000 genes, each cell expresses only those genes that it needs to become a nerve cell, immune cell, or any of the other hundreds of cell types in the body.

Each cell’s fate is largely determined by chemical modifications to the proteins that decorate its DNA; these modification in turn control which genes get turned on or off. When cells copy their DNA to divide, however, they lose half of these modifications, leaving the question: How do cells maintain the memory of what kind of cell they are supposed to be?

A new MIT study proposes a theoretical model that helps explain how these memories are passed from generation to generation when cells divide. The research team suggests that within each cell’s nucleus, the 3D folding pattern of its genome determines which parts of the genome will be marked by these chemical modifications.

Researchers at the University of Pittsburgh and KU Leuven have discovered a suite of genes that influence head shape in humans. These findings, published this week in Nature Communications, help explain the diversity of human head shapes and may also offer important clues about the genetic basis of conditions that affect the skull, such as craniosynostosis.

By analyzing measurements of the cranial vault —the part of the skull that forms the rounded top of the head and protects the brain—the team identified 30 regions of the genome associated with different aspects of head shape, 29 of which have not been reported previously.

“Anthropologists have speculated and debated the genetics of cranial vault shape since the early 20th century,” said co-senior author Seth Weinberg, Ph.D., professor of oral and craniofacial sciences in the Pitt School of Dental Medicine and co-director of the Center for Craniofacial and Dental Genetics.